Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Total Debt (2022 - 2025)

Historic Total Debt for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $14.2 million.

  • Orchestra BioMed Holdings' Total Debt changed N/A to $14.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.2 million, marking a year-over-year change of. This contributed to the annual value of $14.3 million for FY2024, which is N/A changed from last year.
  • Orchestra BioMed Holdings' Total Debt amounted to $14.2 million in Q3 2025.
  • Orchestra BioMed Holdings' 5-year Total Debt high stood at $14.4 million for Q2 2025, and its period low was $9.5 million during Q1 2023.
  • For the 4-year period, Orchestra BioMed Holdings' Total Debt averaged around $12.2 million, with its median value being $12.9 million (2022).